UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934


                       FOR THE PERIOD ENDED: March 31, 1998
                        COMMISSION FILE NUMBER: 333-06718

                                  VIROPRO INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


            NEVADA                                            13-3124057
-------------------------------                         --------------------
(State or other jurisdiction of                         (IRS Employer
incorporation or organization)                           Identification No.)

                   3601 NE 5th Avenue, Oakland Park, Florida
          ------------------------------------------------------------
          (Address, including zip code, of principal executive offices)

                                 (954) 565-2864
               ---------------------------------------------------
              (Registrant's telephone number, including area code)

    Food Concepts, Inc., 6601 Lyons Rd, Ste. C 12, Coconut Creek, Fl. 33073
    ------------------------------------------------------------------------
(Former name, former address & former fiscal year, if changed since last report)

Indicate by check  mark whether the  registrant (1) has filed all  documents and
reports required to be filed by Sections 13 or 15(d) of  the Securities Exchange
Act of 1934 during the preceding  12 months (or for such shorter period that the
registrant was required to  file such reports), and (2) has been subject to such
filings for the past 90 days.

YES  ( )    NO  (X)

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

As of  March 31, 1998, the  number of  the Company's  shares of par  value $.001
common stock outstanding was 7,474,749.

<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                 MARCH 31, 1998


                                      INDEX


Part I - FINANCIAL INFORMATION

Item 1 - Financial Statements

Condensed Consolidated Balance Sheet..........................................3

Consolidated Statements of Operation..........................................4

Consolidated Statements of Cash Flow..........................................5

Notes to Financial Statements.................................................6

Item 2 - Management's Discussion and Analysis of Financial Condition and
            Results of Operations.............................................7

PART II - OTHER INFORMATION...................................................9


SIGNATURES...................................................................10



































<PAGE>
                                  Viropro, Inc
                      Condensed Consolidated Balance Sheet
                                 March 31, 1998
                                   (Unaudited)

                                     ASSETS

Current  Assets

Accounts Receivable                                               $      53,846
Inventory                                                                82,523
Due from It's Coffee Lover's                                             29,179
                                                                  --------------
                         Total Current Assets                           165,548
                                                                  --------------

Fixed Assets (Net Of Depreciation of $47,849)                            26,826
                                                                  --------------

                               Other Assets                              19,002
                                                                  --------------

                                   Total Assets                   $     211,376
                                                                  ==============

                      LIABILITIES and SHAREHOLDERS' EQUITY

Current Liabilities, Accounts Payable and
                             Accrued Expenses                     $      55,347
                                                                  --------------

                  Total Current Liabilities                              55,347
                                                                  --------------

Shareholders' Equity
  Common Stock, $.001 par value; authorized 50,000,000
     shares, issued and outstanding 7,474,749 shares                      7,475
                    Additional Paid in Capital                        1,016,640
                            Retained Earnings                          (868,086)
                                                                  --------------

                   Total Shareholders' Equity                           156,029
                                                                  --------------

     Total Liabilities and Shareholders' Equity                   $     211,376
                                                                  ==============













The accompanying notes are an integral part of these financial statements.


<PAGE>
                                  Viropro, Inc.
                Condensed Consolidated  Statements of Operations
                              For the Nine Months Ended

                                                  March 31, 1998  March 31, 1997
                                                    (Unaudited)    (Unaudited)
                                                  --------------  --------------

Sales                                             $     492,737   $     910,169
Cost of Sales                                           203,796         429,486
                                                  --------------  --------------
Gross Profit                                            288,941         480,683
Operating Expenses                                      343,082         455,598
                                                  --------------  --------------
Operating Income (Loss)                                 (54,141)         25,085
Other  Income  (Expenses)
Interest Expense                                         (2,256)        (11,620)
                                                  --------------  --------------
Net Income (Loss)                                 $     (56,397)  $      13,465
                                                  ==============  ==============

Net Loss Per Share, Basic and Diluted                     (.008)          (.002)
                                                  ==============  ==============
Weighted Average Number of Common Shares
  Outstanding, Basic and Diluted                      6,674,416       6,671,999
                                                  ==============  ==============



                                  Viropro, Inc.
                Condensed Consolidated  Statements of Operations
                            For the Three Months Ended

                                                  March 31, 1998  March 31, 1997
                                                    (Unaudited)    (Unaudited)
                                                  --------------  --------------

Sales                                             $     119,568   $     146,465

Cost of Sales                                            52,252          63,113
                                                  --------------  --------------
Gross Profit                                             67,316          83,352
Operating Expenses                                       39,970          98,454
                                                  --------------  --------------
Operating Income (Loss)                                  27,346         (15,102)
Other  Income  (Expenses)
Interest Expense                                         (1,000)         (7,000)
                                                  --------------  --------------

Net Income (Loss)                                 $      26,346  $      (22,102)
                                                  ==============  ==============
Net Gain (Loss) Per Share, Basic and Diluted              .004            (.003)
                                                  ==============  ==============
Weighted Average Number of Common Shares
  Outstanding, Basic and Diluted                      6,679,251       6,671,999
                                                  ==============  ==============


The accompanying notes are an integral part of these financial statements.


<PAGE>
                                    Viropro, Inc
                  Condensed Consolidated Statements of Cash Flow
                       For the Nine Months Ended March 31,

                                                    For the Nine Months Ended
                                                  March 31, 1998  March 31, 1997
                                                    (Unaudited)    (Unaudited)
                                                  --------------  --------------

Net Income (Loss)                                 $     (56,397)  $      13,465

Adjustments to Reconcile Net Income (Loss) to
  Net cash used for operating  Activities:
    Depreciation and Amortization                         9,464          8,564
Changes in Assets and Liabilities:
  (Increase) Decrease in Accounts Receivable             56,809         53,477
  (Increase) Decrease in Inventory                       70,253       (122,058)
  (Increase) Decrease in Other Assets                       -           (4,555)
  Increase (Decrease) in Accounts  Payable
    and Accrued Expenses                                (43,260)       (66,366)
  (Increase) Decrease in Refundable Deposits                -           (5,912)
                                                  --------------  --------------
    Net Cash Provided in Operating Activities            36,869        (123,385)
                                                  --------------  --------------

Cash Flow From Investing Activities
  Purchase of Fixed Assets                               (6,360)         (1,121)
  (Increase) Decrease in Loans Receivable                   750             -
  (Increase) Decrease in Due From
    Related Companies                                   (29,179)            -
                                                  --------------  --------------
                                                        (34,789)         (1,121)
                                                  --------------  --------------

Cash  Flow  From  Financing  Activities:
  Increase (Decrease) in Notes Payable                      -           (42,792)
  Increase (Decrease) in S/T Notes Payable               (7,245)
  Common Stock                                              -           125,000
                                                 -------------------------------
                                                         (7,245)         82,208
                                                  --------------  --------------

Net Increase (Decrease) in Cash                          (5,165)        (42,298)

Cash (Overdraft) Beginning of Period                       (269)        (11,201)
                                                  --------------  --------------

Cash (Overdraft) End of Period                    $      (5,434)  $     (53,499)
                                                  ==============  ==============










The accompanying notes are an integral part of these financial statements.


<PAGE>
                                  VIROPRO, INC.
                          NOTES TO FINANCIAL STATEMENTS


NOTE  -  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

BASIS  OF  PRESENTATION

The  condensed  consolidated  balance  sheet  as  of March 31, 1998, the related
periods  ended  March  31,  1998  and March 31, 1997, and the three-month period
ended  March  31,  1998  and 1997 and the nine month period ended March 31, 1998
and  March 31, 1997, the related condensed consolidated statements of cash flows
for  the  nine  month  periods  ended  March  31,  1998  and  March 31, 1997 are
unaudited.  In the opinion of management, all adjustments necessary consisted of
normal  recurring items.  Interim results may not be indicative of results for a
full  year.

The  condensed  consolidated  financial  statements  and  notes are presented as
permitted  on  Form  10-QSB  and  do  not  contain  information  included in the
Company's  annual consolidated statements and notes.  The condensed consolidated
balance  sheet, was derived from the Company's financial statements, but may not
include  all  disclosures  required by generally accepted accounting principles.
These  condensed consolidated financial statements should be read in conjunction
with the consolidated financial statements and related notes thereto included in
the  Company's  June  30,  1997  financial  statements.




































<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                 MARCH 31, 1998

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

        AND RESULTS OF OPERATIONS.

General

The  discussion  and analysis set forth below should be read in conjunction With
our  Financial  Statements  and the related Notes thereto appearing elsewhere in
this quarterly report. The information presented for the nine months ended March
31,  1998 and 1997 was derived from unaudited financial statements which, in our
opinion,  reflect  all   adjustments  (consisting   only  of  normal   recurring
adjustments)  necessary  for  a  fair  presentation.

Forward  Looking-Statements.  When  used  in  this  report,  press  releases and
elsewhere  by  the  management  of  the  Company  from  time  to time, the words
"believes", "anticipates", and "expects" and similar expressions are intended to
identify   forward-looking   statements   that   involve   certain   risks   and
uncertainties. Additionally, certain statements contained in this discussion may
be  deemed  forward-looking  statements  that  involve  a  number  of  risks and
uncertainties.  Among  the  factors  that  could  cause actual results to differ
materially  are  the  following:  the ability of the Company to meet its working
capital  and  liquidity  needs, the status of relations between the Company, its
primary  customers  and  distributors,  the  availability  of  long-term credit,
unanticipated  changes  in   the  U.S.  and  international  economies,  business
conditions and the timely development and acceptance of new products, the impact
of  competitive products and pricing, and other risks detailed from time to time
in  the Company's SEC reports. Readers are cautioned not to place undue reliance
on  these forward-looking statements which speak only as of the date hereof. The
Company  undertakes  no obligation to publicly release the results of any events
or  circumstances  after  the  date  hereof  or  to  reflect  the  occurrence of
unanticipated  events.

Going  Concern.  The  Company's  viability as a going concern has been dependent
since inception upon its ability to raise sufficient working capital from equity
and  debt  financing. The Company experienced a loss from operations in 1998 and
had  a working capital deficit at March 31, 1998. The Company experienced a loss
from  operations  of  $56,397  for  the  nine  months  ended March 31, 1998. See
"Liquidity  and  Capital  Resources,"  below.

Results  of  Operations

Three  Months Ended March 31, 1998, compared to the Three Months Ended March 31,
1997

Net  sales  for  the  three months ended March 31, 1998, decreased by $26,897 to
$119,568  from  net sales of $146,465 for the three months ended March 31, 1997.
The decrease in sales was the result of the Company's decision to cease the sale
of a certain line of coffee that has been deemed by management as an ineffective
loss  leader.

Cost of sales for the three months ended March 31, 1998, decreased by $10,861 to
$52,252  from  $63,113  for  the three months ended March 31, 1997. The decrease
resulted  from the decrease in sales and the corresponding decrease in inventory
purchases.

Gross  profit for the three months ended March 31, 1998, was $67,316, or (56.3%)
of net sales, compared to gross profit of $83,352 or 56.9% of net sales, for the
three  months  ended March 31, 1997. The decrease in gross profit percentage was
primarily  due  to  an  adjustment  of  inventory.
<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                MARCH 31, 1998



Operating  expense  decreased  by  $58,484 to $39,970 for the three months ended
March  31,  1998,  from  $98,454  for the three months ended March 31, 1997. The
decrease  in  operating  expenses resulted from a decrease in salaries and other
general  and  administrative  expenses.

Nine  Months  Ended  March 31, 1998, compared to the Nine Months Ended March 31,
1997

Net  sales  for  the  nine months ended March 31, 1998, decreased by $417,432 to
$492,737 from $910,169 for the nine months ended March 31, 1997. The decrease in
sales  was  the  result of the Company's decision to cease the sale of a certain
line of coffee that has been deemed by management as an ineffective loss leader.

Cost of sales for the nine months ended March 31, 1998, decreased by $225,690 to
$203,796  from  $429,486 for the nine months ended March 31, 1997.  The increase
resulted  from the decrease in sales and the corresponding decrease in inventory
purchases.

Gross profit for the nine months ended March 31, 1998, was $288,941, or 58.6% of
net sales, compared to $480,683 or 52.8% of net sales, for the nine months ended
March  31,  1997.  The  increase in gross profit percentage was primarily due to
relatively  higher  gross  margins  due  to  the  elimination of the loss leader
product  line.

Operating  expense  decreased  by $112,516 to $343,082 for the nine months ended
March  31,  1998,  from  $455,598  for the nine months ended March 31, 1997. The
decrease  in  operating  expenses resulted from a decrease in salaries and other
general  and  administrative  expenses.

Liquidity  and  Capital  Resources

Our  viability  as  a  going  concern  is  dependent  upon  our ability to raise
sufficient  working.  The  Company experienced a loss from operations during the
nine months ended March 31, 1998 and 1997. As a result, the Company has faced an
on-going  liquidity  deficit.  Working  capital  may vary from time to time as a
result  of  seasonal inventory requirements and the level of accounts receivable
balances.

The  Company  has  incurred  significant  net losses and negative cash flows for
operations since its organization. The Company has funded these losses primarily
from  the  issuance  of common stock to the Company's founders, loans by related
parties, loans by third party lenders and the private placement of the Company's
securities  to  individuals.  The  Company  will be dependent in the foreseeable
future  on  raising  capital  on  a  debt  or equity basis to meet its operating
expenses,  as  it  will  in all probability continue to incur substantial losses
through  calendar  year  1998.  The  Company anticipates that it will be able to
continue  to  obtain  working  capital  through  the  proceeds of equity or debt
financing  on  a  private  basis,  and  also  from operating income. The Company
competes for capital with a significant number of other businesses. Accordingly,
although  the  Company  has  in the past been able to obtain capital to meet its
operating  losses,  there  can  be no assurance that the Company will be able to
continue  to  meet its operating expenses from its fund-raising activities until
such  time,  if  any,  as  the  Company  is  able  to  operate  at  a  profit.





<PAGE>
                                  VIROPRO, INC.
                                   FORM 10-QSB
                                 MARCH 31, 1998


PART  II

OTHER  INFORMATION

Item  1.  Legal  Proceedings.

NONE

Item  2.  Changes  in  Securities.

NONE

3.       Defaults  Upon  Senior  Securities.

None.

Item  4.  Submission  of  Matters  to  a  Vote  of  Security-Holders.

None

Item  5.  Other  Information.

NONE


Item  6.  Exhibits  and  Reports  on  Form  8-K.

(a)      Exhibit 27, Financial Data Schedule as required for electronic filing.

(b)      Reports  on  Form  8-K

The  Company  filed  two  Form  8-Ks  on  April  16,  1998  and  June  11,  1998



                                    SIGNATURE

In  accordance  with  the requirements of the Security Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned,
duly  authorized.


VIROPRO, INC.



Date: March 14, 2001                     By: /s/ Hugh Johnson
                                         --------------------------------
                                         Hugh Johnson, President